Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4976
CALL
Essential Utilities
WTRG
$11.2B
| $83K | ﹤0.01% |
2,500
+1,500
| +150% | +$50.3K |
|
|
WIRE
4977
DELISTED
Encore Wire Corp
WIRE
| $83K | ﹤0.01% |
1,863
-10,947
| -85% | -$460K |
|
|
FOE
4978
DELISTED
Ferro Corporation
FOE
| $83K | ﹤0.01% |
3,735
-22,434
| -86% | -$437K |
|
4979
iShares MSCI Singapore ETF
EWS
$1.05B
| $82K | ﹤0.01% |
3,360
-11,250
| -77% | -$275K |
|
4980
FIVE9
FIVN
$2.27B
| $82K | ﹤0.01% |
3,437
-2,273
| -40% | -$49.3K |
|
4981
Icahn Enterprises
IEP
$5.01B
| $82K | ﹤0.01% |
1,495
-9,388
| -86% | -$494K |
|
4982
PUT
Macerich
MAC
$7.2B
| $82K | ﹤0.01% |
1,500
-100
| -6% | -$5.61K |
|
4983
National Grid
NGG
$80.7B
| $82K | ﹤0.01% |
1,470
+1,469
| +146,900% | +$82K |
|
4984
CALL
Prologis
PLD
$131B
| $82K | ﹤0.01% |
1,300
-5,200
| -80% | -$320K |
|
4985
PUT
Pentair
PNR
$11B
| $82K | ﹤0.01% |
1,787
+1,191
| +200% | +$51.2K |
|
|
LNCE
4986
DELISTED
Snyders-Lance, Inc.
LNCE
| $82K | ﹤0.01% |
2,143
+1,669
| +352% | +$60.2K |
|
4987
CALL
AeroVironment
AVAV
$8.51B
| $81K | ﹤0.01% |
1,500
-5,700
| -79% | -$243K |
|
4988
CALL
Broadridge
BR
$18.9B
| $81K | ﹤0.01% |
1,000
+900
| +900% | +$69.3K |
|
4989
CALL
Energy Recovery
ERII
$457M
| $81K | ﹤0.01% |
10,200
-6,200
| -38% | -$44.3K |
|
4990
CALL
Synopsys
SNPS
$76.7B
| $81K | ﹤0.01% |
+1,000
| New | +$77.6K |
|
|
VIVO
4991
DELISTED
Meridian Bioscience Inc
VIVO
| $81K | ﹤0.01% |
5,616
-5,009
| -47% | -$71.6K |
|
|
SAFM
4992
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $81K | ﹤0.01% |
+500
| New | +$69.4K |
|
|
CLD
4993
DELISTED
Cloud Peak Energy Inc
CLD
| $81K | ﹤0.01% |
22,430
+8,208
| +58% | +$27.5K |
|
|
ZOES
4994
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $81K | ﹤0.01% |
6,396
-7,372
| -54% | -$89.8K |
|
4995
PUT
Crane NXT
CXT
$3.01B
| $80K | ﹤0.01% |
2,879
-2,015
| -41% | -$54K |
|
4996
Darling Ingredients
DAR
$9.19B
| $80K | ﹤0.01% |
4,526
-15,351
| -77% | -$260K |
|
4997
Entravision Communication
EVC
$1.07B
| $80K | ﹤0.01% |
13,966
+13,223
| +1,780% | +$79.7K |
|
4998
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.75B
| $80K | ﹤0.01% |
645
| – | – |
|
4999
GDS Holdings
GDS
$6.55B
| $80K | ﹤0.01% |
+7,100
| New | +$69.2K |
|
5000
Ironwood Pharmaceuticals
IRWD
$683M
| $80K | ﹤0.01% |
6,089
+4,602
| +309% | +$63.3K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.